UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8221) 8221
Newsletter (47) 47
Book Chapter (20) 20
Magazine Article (9) 9
Newspaper Article (4) 4
Publication (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6705) 6705
female (4687) 4687
male (4579) 4579
mitomycin - administration & dosage (4062) 4062
middle aged (4037) 4037
science & technology (3858) 3858
life sciences & biomedicine (3785) 3785
aged (3468) 3468
mitomycin (2928) 2928
adult (2835) 2835
antineoplastic combined chemotherapy protocols - therapeutic use (2631) 2631
mitomycins - administration & dosage (2246) 2246
fluorouracil - administration & dosage (1971) 1971
combined modality therapy (1675) 1675
animals (1451) 1451
oncology (1441) 1441
treatment outcome (1357) 1357
cisplatin - administration & dosage (1319) 1319
mitomycin c (1227) 1227
ophthalmology (1154) 1154
doxorubicin - administration & dosage (1070) 1070
antibiotics, antineoplastic - administration & dosage (989) 989
follow-up studies (964) 964
surgery (934) 934
chemotherapy (843) 843
aged, 80 and over (827) 827
mitomycin - therapeutic use (795) 795
retrospective studies (792) 792
drug administration schedule (725) 725
survival rate (718) 718
abridged index medicus (716) 716
antineoplastic combined chemotherapy protocols - adverse effects (711) 711
cancer (700) 700
prospective studies (687) 687
antineoplastic combined chemotherapy protocols - administration & dosage (674) 674
mice (664) 664
stomach neoplasms - drug therapy (648) 648
antineoplastic agents - administration & dosage (625) 625
prognosis (617) 617
mitomycin - adverse effects (615) 615
infusions, intra-arterial (587) 587
chemotherapy, adjuvant (577) 577
adenocarcinoma - drug therapy (567) 567
urinary bladder neoplasms - drug therapy (564) 564
neoplasm staging (544) 544
liver neoplasms - secondary (538) 538
liver neoplasms - drug therapy (537) 537
time factors (521) 521
lung neoplasms - drug therapy (519) 519
alkylating agents - administration & dosage (495) 495
mitomycins - therapeutic use (493) 493
administration, intravesical (487) 487
trabeculectomy (476) 476
care and treatment (439) 439
survival analysis (437) 437
administration, topical (416) 416
carcinoma, squamous cell - drug therapy (413) 413
glaucoma - surgery (412) 412
liver neoplasms - therapy (396) 396
intraocular pressure (392) 392
rats (383) 383
antibiotics, antineoplastic - therapeutic use (382) 382
drug therapy, combination (381) 381
stomach neoplasms - pathology (376) 376
mitomycins - adverse effects (373) 373
glaucoma (365) 365
dose-response relationship, drug (359) 359
medicine & public health (356) 356
mitomycin - pharmacology (351) 351
hepatic artery (338) 338
breast neoplasms - drug therapy (321) 321
antineoplastic agents - therapeutic use (320) 320
research (318) 318
adolescent (316) 316
tegafur - administration & dosage (306) 306
urology & nephrology (305) 305
pharmacology & pharmacy (300) 300
postoperative complications (294) 294
cyclophosphamide - administration & dosage (284) 284
disease-free survival (284) 284
remission induction (283) 283
hyperthermia, induced (280) 280
stomach neoplasms - surgery (275) 275
carcinoma, non-small-cell lung - drug therapy (271) 271
analysis (269) 269
urinary bladder neoplasms - pathology (269) 269
radiology, nuclear medicine & medical imaging (258) 258
fluorouracil - therapeutic use (251) 251
clinical trials as topic (248) 248
health aspects (247) 247
fluorouracil - adverse effects (246) 246
neoplasm metastasis (244) 244
methotrexate - administration & dosage (238) 238
epirubicin - administration & dosage (237) 237
risk factors (236) 236
carcinoma, transitional cell - drug therapy (233) 233
recurrence (233) 233
bleomycin - administration & dosage (232) 232
carcinoma, hepatocellular - therapy (232) 232
lymphatic metastasis (232) 232
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7048) 7048
Japanese (1485) 1485
German (172) 172
Chinese (131) 131
French (115) 115
Spanish (55) 55
Italian (52) 52
Russian (34) 34
Portuguese (28) 28
Polish (9) 9
Korean (6) 6
Czech (5) 5
Norwegian (5) 5
Bulgarian (4) 4
Turkish (4) 4
Hebrew (3) 3
Slovak (3) 3
Danish (2) 2
Lithuanian (2) 2
Dutch (1) 1
Hungarian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 1528-0020, 11/2008, Volume 112, Issue 10, pp. 4017 - 4023
Journal Article
Journal Article
Radiation research, ISSN 0033-7587, 06/2018, Volume 189, Issue 6, pp. 560 - 578
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 08/2006, Volume 24, Issue 23, pp. 3726 - 3734
Journal Article
Journal Article
Breast cancer research : BCR, ISSN 1465-5411, 03/2012, Volume 14, Issue 2, pp. R47 - R47
Introduction: Mutations affecting p53 or its upstream activator Chk2 are associated with resistance to DNA-damaging chemotherapy in breast cancer. ATM (Ataxia... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Predictive Value of Tests | Prospective Studies | Humans | Gene Expression Regulation, Neoplastic | Epirubicin - administration & dosage | Tumor Suppressor Protein p53 - genetics | Fluorouracil - therapeutic use | Tumor Suppressor Protein p53 - therapeutic use | Anthracyclines - administration & dosage | Fluorouracil - administration & dosage | Tumor Suppressor Proteins - genetics | Cell Cycle Proteins - genetics | Female | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Promoter Regions, Genetic | Mitomycin - therapeutic use | Protein-Serine-Threonine Kinases - genetics | Ataxia Telangiectasia Mutated Proteins | DNA-Binding Proteins - genetics | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Antibiotics, Antineoplastic - administration & dosage | Drug Resistance, Neoplasm - genetics | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Checkpoint Kinase 2 | Epirubicin - therapeutic use | Breast Neoplasms - mortality | Anthracyclines - therapeutic use | Mutation | Mitomycin - administration & dosage | Cohort Studies | Complications and side effects | Anthracyclines | Mitomycin | Gene mutations | Dosage and administration | Breast cancer | Genetic aspects | Research | Drug therapy | Medical research | Genes | Adjuvant treatment | Gene expression | Ionizing radiation | Analysis | Medicine, Experimental | Tumor proteins | Fluorouracil | Cancer | Index Medicus | Medisinsk genetikk: 714 | VDP | Midical sciences: 700 | Clinical medical sciences: 750 | Medisinske fag: 700 | Onkologi: 762 | Oncology: 762 | Clinical pharmacology: 739 | Basic medical, dental and veterinary sciences: 710 | Klinisk medisinske fag: 750 | Klinisk farmakologi: 739 | Medical genetics: 714 | Basale medisinske, odontologiske og veterinærmedisinske fag: 710
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2010, Volume 28, Issue 19, pp. 3191 - 3198
Journal Article
PloS one, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0171636 - e0171636
Journal Article
Journal Article